Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTimo Kringsen_US
dc.contributor.authorFranz Josef Hansen_US
dc.contributor.authorSasikhan Geibpraserten_US
dc.contributor.authorKarel Terbruggeen_US
dc.contributor.otherUniversity of Torontoen_US
dc.contributor.otherMedizinische Fakultat und Universitats Klinikum Aachenen_US
dc.contributor.otherCHU, Parisen_US
dc.contributor.otherHospital for Sick Children University of Torontoen_US
dc.contributor.otherMahidol Universityen_US
dc.identifier.citationEuropean Radiology. Vol.20, No.11 (2010), 2723-2731en_US
dc.description.abstractThe treatment of pial arteriovenous brain malformations is controversial. Little is yet known about their natural history, their pathomechanisms and the efficacy and risks of respective proposed treatments. It is known that only complete occlusion of the AVM can exclude future risk of haemorrhage and that the rates of curative embolisation of AVMs with an acceptable periprocedural risk are around 20 to 50%. As outlined in the present article, however, partial, targeted embolisation also plays a role. In acutely ruptured AVMs where the source of bleeding can be identified, targeted embolisation of this compartment may be able to secure the AVM prior to definitive treatment. In unruptured symptomatic AVMs targeted treatment may be employed if a defined pathomechanism can be identified that is related to the clinical symptoms and that can be cured with an acceptable risk via an endovascular approach depending on the individual AVM angioarchitecture. This review article gives examples of pathomechanisms and angioarchitectures that are amenable to this kind of treatment strategy. © 2010 The Author(s).en_US
dc.rightsMahidol Universityen_US
dc.titlePartial "targeted" embolisation of brain arteriovenous malformationsen_US
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.